LeMaitre Vascular, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for LMAT, updated each market day.
LMAT AI Sentiment
AI sees no strong directional signal for LeMaitre Vascular, Inc. stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About LeMaitre Vascular, Inc.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
Sector
Exchange
Market Cap
$2,567,349,293
Cap Tier
Employees
655
Headquarters
BURLINGTON, MA
Listed Since
Oct. 19, 2006
Website
LMAT Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
LMAT Volatility
LeMaitre Vascular, Inc. has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
